首页> 美国卫生研究院文献>Journal of Clinical and Diagnostic Research : JCDR >Association Between Serum Cystatin C and Creatinine in Chronic Kidney Disease Subjects Attending a Tertiary Health Care Centre
【2h】

Association Between Serum Cystatin C and Creatinine in Chronic Kidney Disease Subjects Attending a Tertiary Health Care Centre

机译:慢性肾脏病患者就读三级卫生保健中心血清胱抑素C和肌酐之间的关联。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionChronic Kidney Disease (CKD) is an emerging health problem due to the increasing prevalence of conditions like diabetes mellitus and hypertension. Most patients are diagnosed during the later stages of CKD when the clinical symptoms become apparent. There is a need for early diagnosis to prevent disease progression and associated morbidities. Serum Creatinine (SCr) is commonly used among clinicians to determine renal function. However, SCr is affected by several factors and cannot be entirely relied upon. In pursuit of an alternative indicator of renal function, several biomarkers have been discovered and their utility in prompt diagnosis has been evaluated. Among such biomarkers, serum cystatin C (SCysC) has been extensively studied.
机译:简介由于诸如糖尿病和高血压等疾病的患病率不断上升,慢性肾脏病(CKD)是一个正在出现的健康问题。当临床症状变得明显时,大多数患者在CKD晚期被诊断出。需要早期诊断以预防疾病进展和相关的发病率。血清肌酐(SCr)通常在临床医生中用于确定肾功能。但是,SCr受几个因素影响,不能完全依赖。为了追求肾脏功能的替代指标,已经发现了几种生物标志物,并评估了它们在迅速诊断中的效用。在这些生物标记物中,血清半胱氨酸蛋白酶抑制剂C(SCysC)已被广泛研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号